LEfSe is known to reduce false positives and can highlight biological consistency across subclasses, while the KruskalWallis test used alone can achieve a lower false-negative rate compared to LEfSe 38
A real-world study found new GERD development at a rate of 67.04 events per 1,000 person-years among tirzepatide users, compared to 51.46 in the comparison group
The objective of this review is to critically assess the current evidence surrounding their mechanisms of action, clinical indications, efficacy, and safety profiles, with particular emphasis on regulatory and translational considerations
We treat kind of the full gamut of individuals and so however we can help that's my goal is impact and so glad to continue the conversation if everyone is excited about learning more
No tirzepatide is contraindicated in individuals with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)